AC-03-636

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAC-03-636
Drug Alias NameR-Amphinaseamphinase (Alfacell)recombinant amphinase 2amphinase (Tamir)antiviral ribonuclease (Alfacell) +[7] 
ClassificationBiologics
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasmsFlavivirus InfectionsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTamir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTamir Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsNeoplasmsFlavivirus InfectionsSevere Acute Respiratory Syndrome

Other Information

ATC CodeN/A
Related LinksN/A